Results 31 to 40 of about 390,856 (338)

High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. [PDF]

, 2011
BackgroundPatients with systemic lupus erythematosus (SLE) are at increased risk of atherosclerosis, even after accounting for traditional risk factors.
Charles-Schoeman, Christina, Chernishof, Marissa, FitzGerald, John, Gorn, Alan, Grossman, Jennifer, Hahn, Bevra H, La Cava, Antonio, McMahon, Maureen, Ragavendra, Nagesh, Sahakian, Lori, Skaggs, Brian J, Wallace, Daniel J, Weisman, Michael, Witztum, Joseph L, Wong, Weng Kee   +14 more
core   +2 more sources

Cutaneous Manifestations of “Lupus”: Systemic Lupus Erythematosus and Beyond

International Journal of Rheumatology, 2021
Lupus, Latin for “wolf,” is a term used to describe many dermatologic conditions, some of which are related to underlying systemic lupus erythematosus, while others are distinct disease processes.
Elizabeth E Cooper, Catherine E. Pisano, Samantha C Shapiro   +2 more
semanticscholar   +1 more source

Association between Toxoplasma gondii and systemic lupus erythematosus: A systematic review and meta-analysis

Journal of Translational Autoimmunity, 2022
Infecting approximately one-third of the world's population, the intraneuronal parasite Toxoplasma gondii has been associated with several autoimmune diseases.
Pierce Bassett, Brinley N. Zabriskie, Ashley Catchpole, Dawson Hedges   +3 more
doaj   +1 more source

IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study. [PDF]

, 2015
IgG anti-apolipoprotein A-1 (IgG anti-apoA-1) antibodies are present in patients with systemic lupus erythematosus (SLE) and may link inflammatory disease activity and the increased risk of developing atherosclerosis and cardiovascular disease (CVD) in ...
Alber, KF, Bassett, P, Chambers, S, Croca, S, Davari, M, Giles, I, Ioannou, Y, Isenberg, D, Leach, O, Rahman, A   +9 more
core   +1 more source

Mapping Systemic Lupus Erythematosus heterogeneity at the single-cell level

Nature Immunology, 2020
Patients with systemic lupus erythematosus (SLE) display a complex blood transcriptome whose cellular origin is poorly resolved. Using single-cell RNA sequencing, we profiled ~276,000 peripheral blood mononuclear cells from 33 children with SLE with ...
Djamel Nehar-Belaid, Seunghee Hong, R. Marches, Guo Chen, M. Bolisetty, Jeanine Baisch, Lynnette Walters, M. Punaro, R. Rossi, C. Chung, Richie Huynh, Prashant Singh, W. Flynn, Joy-Ann Tabanor-Gayle, N. Kuchipudi, A. Mejías, Magalie A. Collet, Anna Lisa Lucido, K. Palucka, P. Robson, S. Lakshminarayanan, O. Ramilo, Tracey Wright, V. Pascual, J. Banchereau   +24 more
semanticscholar   +1 more source

Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus [PDF]

, 2017
Background: The aim was to assess the attainability and outcome of the lupus low disease activity state (LLDAS) in the early stages of systemic lupus erythematosus (SLE).
CAPPELLAZZO, GIULIA, Cauli, Alberto, Chessa, Elisabetta, Congia, Mattia, Floris, Alberto, Mathieu, Alessandro, Piga, Matteo   +6 more
core   +1 more source

Acute interstitial nephritis and drug-induced systemic lupus erythematosus due to chlorthalidone and amiodarone: A case report

SAGE Open Medical Case Reports, 2020
Drug-induced lupus erythematosus has features distinct from primary systemic lupus erythematosus. It can occur with a wide variety of agents that result in the generation of anti-histone or other types of antibodies.
Umut Selamet, Ramy M Hanna, Anthony Sisk, Lama Abdelnour, Lena Ghobry, Ira Kurtz   +5 more
doaj   +1 more source

Systemic Lupus Erythematosus

DeckerMed Family Medicine, 2019
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune illness characterized by autoantibodies directed at nuclear antigens that cause clinical and laboratory abnormalities, such as rash, arthritis, leukopenia and thrombocytopenia, alopecia, fever, nephritis, and neurologic disease.
Kyriakos A. Kirou, Michael D. Lockshin
openaire   +1 more source

Serum interleukin-17 levels are associated with nephritis in childhood-onset systemic lupus erythematosus

Clinics, 2015
OBJECTIVES: To determine the serum interleukin-17 (IL-17) levels in childhood-onset systemic lupus erythematosus patients and to evaluate the association between IL-17 and clinical manifestations, disease activity, laboratory findings and treatment ...
Karina de Oliveira Peliçari, Mariana Postal, Nailú Angelica Sinicato, Fernando Augusto Peres, Paula Teixeira Fernandes, Roberto Marini, Lilian Tereza Lavras Costallat, Simone Appenzeller   +7 more
doaj   +1 more source

Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort [PDF]

, 2015
Objectives. The anti-dsDNA antibodies are a marker for Systemic Lupus Erythematosus (SLE) and 70–98% of patients test positive. We evaluated the demographic, clinical, laboratory, and therapeutical features of a monocentric SLE cohort according to the ...
Alessandri, Cristiano, Ceccarelli, Fulvia, Conti, Fabrizio, Marocchi, Elisa, Massaro, Laura, Miranda, Francesca, Perricone, Carlo, Spinelli, FRANCESCA ROMANA, Truglia, Simona, Valesini, Guido   +9 more
core   +1 more source